Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-1331015

  • Global Genetic Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: April 2016 | Report Code: HBI-1331015

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Genetic testing are the medical tests that identify changes in chromosomes, proteins or in genes. These types of tests help suspect and confirm any type of gene abnormality in a person. They also help in predicting the onset of certain diseases. Genetic testing represents the most rapidly expanding segment in the molecular diagnostics market globally. The global genetic testing market is expected to grow with a CAGR of 10% during the forecast period 2016-2023.  The key factor contributing to the growth of the global genetic testing is increasing number of chronic and genetic diseases and rise in the market of personized medicine. The key factors driving the global genetic testing market are:

  • Early confirmation of genetic disorder
  • Minimal procedure risk
  • Increase of pipeline genetic tests




Increasing consumer demand for effective and safe way to treat diseases is leading to the increase in genetic testing. Genetic testing is a sophisticated form of medical testing used to identify even the minute changes in genes, proteins or in chromosomes. These tests can confirm suspected genetic condition and help the doctors with better precision towards treating the patients. The conversion of genetic testing from being a service-driven to a product-driven market is expected to provide a thrust to the diagnostic companies for the expansion of their business globally. Genetic tests are helpful in identifying diseases such as cancer and Alzheimer’s and genetic disorders such as cystic fibrosis. Fast screening, technological advancements, accurate detection, increasing adoption of genetic testing in oncology applications, increasing public awareness and demand for customized medicine testing are some of the major factors helping the global genetic testing market grow. Favorable regulation environment, adoption of genetic testing by physicians in daily routine, technological advancement in the field of genetic testing etc., are also the factors driving the global genetic testing market. With advancements in DNA analysis, the scope of genetic testing widens up in different areas, mainly in pharmacogenomics, predictive testing, and prenatal testing and so on. The early detection of genetic disorder reduces mortality rates. Genetic testing also helps in the early detection of breast cancer.

However, due to the extensive knowledge required in genetic testing, it is an expensive process that cannot be afforded by all of the people. This is the major drawback and it affects the growth and affects the market globally.

 

Source: OBRC Analysis

The global genetic testing market is segmented into type and application. Type is further segmented into:

  • Diagnostic testing
  • Newborn screening
  • Carrier testing
  • Prenatal testing





Application is further segmented into:

  • Cancer
  • Prenatal
  • Pharmacogenomics
  • Predisposition





The revenue for the above application segments is specific to the global genetic testing market. However, the total revenue of these applications in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type segment. Geographically, the global genetic testing market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is the leader in global genetic testing market followed by Europe, due to the technological advancements in the field of genetic engineering, increasing prevalence of genetic diseases and high quality of infrastructure. Asia Pacific is the fastest growing market due to increase in number of geriatric population, and advancements in medical field. China has the highest growth rate in APAC. Major countries like Dubai and South Africa also contribute to the growth of global genetic testing market.

The global genetic testing market is segmented into type, application. The type segment of global genetic testing market is further segmented into carrier testing, diagnostic testing, newborn screening and prenatal testing. Application is further segmented into cancer genetic testing, prenatal genetic testing, pharmacogenomics, and predisposition testing. Cancer genetic testing has the largest market share in this segment.

The major market players of the global genetic testing market are:

  • CEPHEID
  • DAAN DIAGNOSTICS LTD.
  • GENENTECH, INC.
  • GENOMICTREE, INC.
  • HTG MOLECULAR DIAGNOSTICS, INC.
  • ILLUMINA, INC
  • INTEGRAGEN S.A
  • OTHERS









Detailed analysis of these companies provided in this report comprises of overview, scot analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as mergers & acquisitions, collaboration, partnership and product launching. For example: Myriad Genetics acquired Assurex health in 2016 which provided a commercial channel in personalized medicine.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such acquisitions as in 2016, Myriad Genetics acquired Assurex health in 2016 which provided a commercial channel in personalized medicine.
  • Provide in detail the different segments such as type and application which affect the global genetic testing market.
  • Provide you the patent analysis of global genetic testing market.
  • Identify and understand the strengths, opportunities, challenges and threat of the global genetic testing market.
  • Provide revenues of major players of the market such as Cepheid, DAAN diagnostics ltd. etc.
  • Provide you the various regulatory policies which affect the global genetic testing market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global genetic testing market offers the longest chain of market segmentation covering major market segmentation based on type and application. For each market segments covered in global genetic testingmarket report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the genetic testing, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model. For the highlevel analysis in the report we provide a comparative analysis of historic and current year data. 

ey findings of the global genetic testing market.

  • North America had the largest revenue share in 2016.
  • Merger and acquisition is the key strategy adopted by the various market players of global genetic testing market.
  • Cancer genetic testing has the largest market share of application segment.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL GENETIC TESTING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. EARLY CONFIRMATION OF GENETIC DISORDER
3.1.2. MINIMAL PROCEDURE RISK
3.1.3. INCREASE OF PIPELINE GENETIC TESTS
3.2. MARKET RESTRAINTS
3.2.1. FALSE POSITIVE AND FALSE NEGATIVE RESULTS
3.2.2. POTENTIAL ADVERSE PERSONAL OR SOCIETAL CONSEQUENCES
3.3. MARKET OPPORTUNITIES
3.3.1. GENETIC COUNCELLING
3.3.2. EXPANSION OF BREAST CANCER GENES TESTING MARKET
3.3.3. NEW AND IMPROVED TECHNOLOGY
3.4.  MARKET CHALLENGES 
3.4.1. HIGH PRICES OF TESTS
3.4.2. RAW MATERIAL AND PRODUCTION COST IS HIGH
 
4. MARKET SEGMENTATION 
4.1. GLOBAL GENETIC TESTING MARKETBY BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT 
4.1.3. DATABASE & ESTIMATION METHODOLOGY
4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.5. OPPORTUNITY MATRIX
4.1.6. MARKET SEGMENTATION 
4.1.6.1. GLOBAL CARRIER TESTING MARKET
4.1.6.1.1. APPLICATION
4.1.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.1.5. KEY CONCLUSIONS
4.1.6.2. GLOBAL DIAGNOSTIC TESTING MARKET
4.1.6.2.1. APPLICATION
4.1.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.2.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.2.5. KEY CONCLUSIONS
4.1.6.3. GLOBAL  NEWBORN SCREENING MARKET
4.1.6.3.1. APPLICATION
4.1.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.3.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.3.5. KEY CONCLUSIONS
4.1.6.4. GLOBAL RENATAL TESTING MARKET
4.1.6.4.1. APPLICATION
4.1.6.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.4.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.4.5. KEY CONCLUSIONS
 
4.2. GLOBAL  GENETIC TESTING MARKET BY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL CANCER MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL PRENATAL MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL PHARMACOGENOMICS MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL PREDISPOSITION MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.4.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
5.2. TOP 10 COMPANY ANALYSIS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.3.1. GLOBAL GENETIC TESTING MARKET BY REGION 
6.3.2. NORTH AMERICA
6.3.2.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
6.3.2.2. TOP COUNTRY ANALYSIS
6.3.2.2.1. U.S. 
6.3.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.1.3. KEY CONCLUSIONS
6.3.2.2.2. CANADA
6.3.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.2.3. KEY CONCLUSIONS
6.3.3. EUROPE
6.3.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.3.3.2. TOP COUNTRY ANALYSIS
6.3.3.2.1. UK
6.3.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.1.3. KEY CONCLUSIONS
6.3.3.2.2. FRANCE
6.3.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.2.3. KEY CONCLUSIONS
6.3.3.2.3. GERMANY
6.3.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.3.3. KEY CONCLUSIONS
6.3.3.2.4. SPAIN
6.3.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.4.3. KEY CONCLUSIONS
6.3.3.2.5. REST OF EUROPE
6.3.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.5.3. KEY CONCLUSIONS
6.3.4. ASIA PACIFIC
6.3.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.3.4.2. TOP COUNTRY ANALYSIS
6.3.4.2.1. CHINA
6.3.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.1.3. KEY CONCLUSIONS
6.3.4.2.2. INDIA
6.3.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.2.3. KEY CONCLUSIONS
6.3.4.2.3. JAPAN
6.3.4.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.4.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.3.3. KEY CONCLUSIONS
6.3.4.2.4. AUSTRALIA
6.3.4.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.4.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.4.3. KEY CONCLUSIONS
6.3.4.2.5. REST OF ASIA PACIFIC
6.3.4.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.4.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.5.3. KEY CONCLUSIONS
6.3.5. ROW
6.3.5.1. INDUSTRY END-USER ANALYSIS 
6.3.5.2. TOP COUNTRY ANALYSIS
6.3.5.2.1. LATIN AMERICA
6.3.5.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.5.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.3.5.2.1.3. KEY CONCLUSIONS
6.3.5.2.2. MIDDLE EAST & AFRICA 
6.3.5.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.3.5.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.3.5.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. CEPHEID
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. DAAN DIAGNOSTICS LTD.
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS 
7.2.6. STRATEGIC ANALYSIS
7.3. GENENTECH, INC.
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. GENOMICTREE, INC.
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. HTG MOLECULAR DIAGNOSTICS, INC.
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS 
7.5.6. STRATEGIC ANALYSIS
7.6. ILLUMINA, INC
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. INTEGRAGEN S.A
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8. LABORATORY CORPORATION OF AMERICA HOLDINGS
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. LUMINEX CORPORATION
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. MOLECULARMD, CORP.
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. MYRIAD GENETICS, INC.
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. NATERA, INC.
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. OXFORD BIODYNAMICS LIMITED
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. PERKINELMER, INC.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL GENETIC TESTING MARKET BY TYPE 2014-2023 ($ MILLION)
2. GLOBAL CARRIER TESTING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL DIAGNOSTIC TESTING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL NEWBORN SCREENING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL GENETIC TESTING MARKET BY   APPLICATION 2014-2023 ($ MILLION)
6. GLOBAL CANCER MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL PRENATAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL PHARMACOGENOMICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL PREDISPOSITION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. NORTH AMERICA  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
11. EUROPE  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
12. ASIA PACIFIC  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
13. REST OF THE WORLD  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL CARRIER TESTING MARKET  2014-2023 ($ MILLION)
2. GLOBAL DIAGNOSTIC TESTING MARKET  2014-2023 ($ MILLION)
3. GLOBAL NEWBORN SCREENING MARKET  2014-2023 ($ MILLION)
4. GLOBAL CANCER MARKET 2014-2023 ($ MILLION)
5. GLOBAL PRENATAL MARKET 2014-2023 ($ MILLION)
6. GLOBAL PHARMACOGENOMICS MARKET 2014-2023 ($ MILLION)
7. GLOBAL PREDISPOSITION MARKET 2014-2023 ($ MILLION)
8. UNITED STATES (U.S.)  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
9. CANADA  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
10. UNITED KINGDOM (UK) GLOBAL  GENETIC TESTING MARKET 2014-2023 ($ MILLION)
11. FRANCE  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
12. GERMANY  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
13. SPAIN   GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
14. ROE  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
15. INDIA  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
16. CHINA  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
17. JAPAN  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
18. AUSTRALIA GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
19. ROAPAC  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
20. LATIN AMERICA   GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)
21. MENA  GLOBAL GENETIC TESTING MARKET 2014-2023 ($ MILLION)

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

UPCOMING REPORTS

No upcoming reports available under this subcategory.

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion